Chlorogenic acid improves glucose tolerance, lipid metabolism, inflammation and microbiota composition in diabetic db/db mice.

Introduction: Chronic and acute chlorogenic acid (CGA) can improve glucose tolerance (GT) and insulin sensitivity (IS). However, whether acute administration of CGA has beneficial effects on hepatic lipid metabolism and cecal microbiota composition remains unclear.

Methods: In the current study, diabetic db/db mice were administered CGA or metformin, and db/m mice were used as controls to explore the effects of CGA on hepatic lipid metabolism, including fatty acid oxidation and transportation and triglyceride (TG) lipolysis and synthesis. Moreover, alterations in the inflammatory response and oxidative stress in the liver and gut microbe composition were evaluated.

Results: The results showed that CGA decreased body weight and improved glucose tolerance and insulin resistance, and these effects were similar to those of metformin. CGA decreased hepatic lipid content by increasing the expression of (carnitine palmitoyltransferase 1a), (Acyl-CoA oxidase 1), (adipose triglyceride lipase), and (hormone-sensitive lipase) and decreasing that of (monoacylglycerol O-acyltransferase 1), (diacylglycerol O-acyltransferase), , and (fatty acid transport protein 4). Additionally, CGA restored the expression of inflammatory genes, including (tumor necrosis factor-alpha), , and , and genes encoding antioxidant enzymes, including (superoxide dismutases 1), (superoxide dismutases 2), and (glutathione peroxidase 1). Furthermore, CGA improved the bacterial alpha and beta diversity in the cecum. Moreover, CGA recovered the abundance of the phylum Bacteroidetes and the genera , and .

Discussion: CGA can improve the antidiabetic effects, and microbes may critically mediate these beneficial effects.